Terms: = Breast cancer AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L AND Treatment
112 results:
1. Case report: A case of Paget disease outside the axillary breast.
Zhou Z; Zhou B; Wu X; Wei W
Medicine (Baltimore); 2024 Mar; 103(13):e37541. PubMed ID: 38552095
[TBL] [Abstract] [Full Text] [Related]
2. Hypoxia-activated XBP1s recruits HDAC2-EZH2 to engage epigenetic suppression of ΔNp63α expression and promote breast cancer metastasis independent of HIF1α.
Chen H; Yu S; Ma R; Deng L; Yi Y; Niu M; Xu C; Xiao ZJ
Cell Death Differ; 2024 Apr; 31(4):447-459. PubMed ID: 38413797
[TBL] [Abstract] [Full Text] [Related]
3. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
4. Neoadjuvant pyrotinib plus trastuzumab and chemotherapy for HER2-positive breast cancer: a prospective cohort study.
Liu L; Zhu M; Wang Y; Li M; Gu Y
World J Surg Oncol; 2023 Dec; 21(1):389. PubMed ID: 38114991
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic analyses of genes associated with anoikis in breast cancer.
Cao J; Ma X; Zhang G; Hong S; Ma R; Wang Y; Yan X; Ma M
PeerJ; 2023; 11():e15475. PubMed ID: 37842046
[TBL] [Abstract] [Full Text] [Related]
6. Investigating the cell membrane localization of PADI4 in breast cancer cells and inhibition of anti-PADI4 monoclonal antibody.
Wang Y; Song X; Song Y; Fang K; Chang X
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17253-17268. PubMed ID: 37804426
[TBL] [Abstract] [Full Text] [Related]
7. Solid-Basaloid Adenoid Cystic Carcinoma of the breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression.
Shamir ER; Bean GR; Schwartz CJ; Vohra P; Wang A; Allard GM; Wolsky RJ; Garcia JJ; Chen YY; Krings G
Mod Pathol; 2023 Dec; 36(12):100324. PubMed ID: 37660928
[TBL] [Abstract] [Full Text] [Related]
8. Low-grade adenosquamous carcinoma of the breast: a clinical, morphological and immunohistochemical analysis of 25 patients.
Lewis G; Fong N; Gjeorgjievski SG; Li XB; Li Z; Wei S; Sturgis CD; Wang C; Komforti M; Zhang H; Downs E; Cui X; McIntire P; Hoda RS; Rowe JJ; Sciallis A; Zhang G
Histopathology; 2023 Aug; 83(2):252-263. PubMed ID: 37067767
[TBL] [Abstract] [Full Text] [Related]
9. Novel diagnostic biomarkers of T cell-mediated tumor killing characteristics for early-stage triple negative breast cancer: A SEER analysis and molecular portraits.
Chang Q; Fan L; Li M; Liu L
Medicine (Baltimore); 2023 Feb; 102(8):e33059. PubMed ID: 36827041
[TBL] [Abstract] [Full Text] [Related]
10. Identification of a Novel Gene Signature with DDR and EMT Difunctionalities for Predicting Prognosis, Immune Activity, and Drug Response in breast cancer.
Zhang P; Li Q; Zhang Y; Wang Q; Yan J; Shen A; Hu B
Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36673982
[TBL] [Abstract] [Full Text] [Related]
11. Sclerosing Adenosis of the Prostate-A Benign Lesion Similar to Prostate cancer: A Case Report and Literature Review.
Yao H; Tang G; Cui Y; Wu J
Am J Mens Health; 2022; 16(6):15579883221143182. PubMed ID: 36527372
[TBL] [Abstract] [Full Text] [Related]
12. HPV-positive cervical squamous cell carcinoma metastasis to the breast, mimicking primary tumor.
de Oliveira-Junior I; Barbin FF; Watanabe AHU; Dos Reis R; da Costa Vieira RA
Breast Dis; 2022; 41(1):407-411. PubMed ID: 36502298
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of p63 immunohistochemistry and shear wave elastography in the diagnosis of indeterminate breast lesions: A prospective study.
Sridhar RK; Chandru R; Pavithra V; Raj DR; Dev B; Sundaram S; Ramya R
J Cancer Res Ther; 2022; 18(6):1738-1742. PubMed ID: 36412438
[TBL] [Abstract] [Full Text] [Related]
14. Possible Involvement of the Upregulation of ΔNp63 Expression Mediated by HER2-Activated Aryl Hydrocarbon Receptor in Mammosphere Maintenance.
Kanno Y; Saito N; Yamashita N; Ota K; Shizu R; Hosaka T; Nemoto K; Yoshinari K
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292946
[TBL] [Abstract] [Full Text] [Related]
15. Tumor Microenvironment Multiple Responsive Nanoparticles for Targeted Delivery of Doxorubicin and CpG Against Triple-Negative breast cancer.
Gu F; Hu C; Cao W; Li C; Xia Q; Gao Y; Liu Y; Gao S
Int J Nanomedicine; 2022; 17():4401-4417. PubMed ID: 36164553
[TBL] [Abstract] [Full Text] [Related]
16. Integrated DNA and RNA Sequencing Reveals Drivers of Endocrine Resistance in Estrogen Receptor-Positive breast cancer.
Xia Y; He X; Renshaw L; Martinez-Perez C; Kay C; Gray M; Meehan J; Parker JS; Perou CM; Carey LA; Dixon JM; Turnbull A
Clin Cancer Res; 2022 Aug; 28(16):3618-3629. PubMed ID: 35653148
[TBL] [Abstract] [Full Text] [Related]
17. Combining Analysis of Tumor-infiltrating Lymphocytes (TIL) and PD-L1 Refined the Prognostication of breast cancer Subtypes.
Ni Y; Tsang JY; Shao Y; Poon IK; Tam F; Shea KH; Tse GM
Oncologist; 2022 Apr; 27(4):e313-e327. PubMed ID: 35380716
[TBL] [Abstract] [Full Text] [Related]
18. [Standardized data on the incidence and mortality of female and male breast cancers in Hungary between 2000 and 2016].
Béres E; Nagy J; Tóth J; Árkosy P; Sipka S
Orv Hetil; 2022 Jan; 163(5):181-186. PubMed ID: 35093928
[TBL] [Abstract] [Full Text] [Related]
19. Leptomeningeal Metastases of the Spine: A Systematic Review.
Palmisciano P; Sagoo NS; Kharbat AF; Kenfack YJ; Bin Alamer O; Scalia G; Umana GE; Aoun SG; Haider AS
Anticancer Res; 2022 Feb; 42(2):619-628. PubMed ID: 35093859
[TBL] [Abstract] [Full Text] [Related]
20. [Clinicopathological analysis of lung metastatic tumor].
Lou N; Niu YR; Yang F; Lu ZH
Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1039-1044. PubMed ID: 34496496
[No Abstract] [Full Text] [Related]
[Next]
